logo-img
Fluent in Spanish, Portuguese, French, English

Navigating Fertility Treatments After Cancer: Empowering Survivors to Build Families

Medically Reviewed by Dr. Silvana Chedid on September 9, 2026

A cancer diagnosis raises many concerns, and for patients of reproductive age, the effect on future fertility is often one of the most pressing. Chemotherapy, radiation, and some surgeries can reduce egg or sperm quality, damage reproductive organs, or bring on early menopause, though the extent of this impact varies by cancer type, treatment protocol, and age at diagnosis. Today, fertility preservation before treatment and a range of assisted reproductive technologies afterward give many cancer survivors realistic options for building a family.

At Chedid Grieco, we work with cancer survivors at every stage of this process, whether that means coordinating fertility preservation before treatment begins or planning IVF, egg donation, or other options once treatment has ended. With nearly 30 years in reproductive medicine, our team is used to working alongside oncology teams to build a plan that respects both a patient’s cancer treatment timeline and their family-building goals.

How Cancer Treatment Affects Fertility

Cancer treatments, while life-saving, can affect reproductive health in both men and women. Chemotherapy, radiation therapy, and some surgical procedures may affect the following:

  • Hormone production
  • Reproductive organs, including the ovaries, uterus, or testicles
  • The quality and quantity of eggs or sperm

The extent of these effects depends on the type of cancer, the treatment protocol used, a patient’s age at diagnosis, and individual health factors. For women, cancer treatment may cause early menopause, damage to the ovaries, or hormone changes that affect ovulation and egg quality. Men may experience reduced sperm production, changes in sperm quality, or reproductive organ damage. Fertility impacts vary a great deal between individuals, and many people retain some reproductive function after treatment, though this cannot be predicted with certainty for any one patient.

The timing of fertility preservation plays a significant role in future family-building options. Patients who preserve eggs, sperm, or embryos before starting cancer treatment generally have more options later, while those who did not have that opportunity may still have paths forward through egg donation or other treatments. Our team reviews each patient’s situation individually to determine what is realistic given their treatment history and current reproductive status.

Fertility Preservation Before Cancer Treatment Begins

When there is time before cancer treatment starts, discussing fertility preservation options with both an oncology team and a fertility specialist can open up more choices later. For women, this usually means egg or embryo freezing, which requires roughly two weeks of ovarian stimulation and a minor retrieval procedure. Ovarian tissue freezing is an alternative for patients who cannot wait even a few weeks, since it does not require stimulation beforehand.

For men, sperm cryopreservation is a fast, well-established option that can typically be completed in a single visit before treatment begins. Patients who are unable to provide a sample, due to illness or the urgency of starting treatment, may still have options through testicular sperm extraction. We go into more detail on these choices in our related article on fertility preservation for patients starting cancer treatment, and our team can help coordinate timing with your oncologist so preservation does not delay necessary cancer care.

What Fertility Treatment Options Are Available for Cancer Survivors?

Cancer survivors have access to a range of assisted reproductive technologies, and the most appropriate option depends on their specific fertility status and overall health following treatment.

Treatment options for cancer survivors include the following:

  • In vitro fertilization using eggs, sperm, or embryos frozen before cancer treatment
  • Egg donation for patients whose ovarian function has been significantly affected
  • Donor sperm for patients experiencing fertility challenges following treatment
  • Gestational surrogacy, when carrying a pregnancy is not medically advisable
  • Advanced techniques such as ovarian tissue transplantation or testicular sperm extraction

Survivors who preserved eggs or embryos before treatment often find IVF provides a fairly direct path to pregnancy. Those who did not have that opportunity may consider egg donation, which allows them to carry a pregnancy using donor eggs. Men who preserved sperm can use those samples for IVF or IUI procedures, while those without preserved samples may consider donor sperm depending on their fertility status after treatment.

Our approach is built around each survivor’s medical history, current health status, and family-building goals, and we coordinate closely with oncology teams to confirm that any fertility treatment is safe given a patient’s specific cancer history.

Timing and Medical Clearance for Cancer Survivors

One of the most important considerations for cancer survivors pursuing fertility treatment is timing and medical clearance. Most oncologists recommend waiting a period of time after finishing treatment before attempting pregnancy, both to allow the body to recover and to help confirm the cancer remains in remission.

Recommended waiting periods vary by cancer type and treatment received, typically ranging from six months to several years. During this time, survivors can work with a fertility team to plan their approach and address preliminary concerns. Medical clearance from an oncology team is an essential step before starting fertility treatment, since it helps confirm that pregnancy and fertility medications will not increase the risk of cancer recurrence and that a patient’s overall health supports a safe pregnancy. According to a 2022 review of fertility outcomes after cancer treatment in the National Institutes of Health’s research database, many cancer survivors who pursue fertility treatment after appropriate clearance go on to have successful pregnancies, though outcomes depend heavily on cancer type, treatment history, and age at diagnosis. Our team coordinates closely with oncologists to confirm every medical consideration has been addressed before moving forward.

How Chedid Grieco Supports Cancer Survivors

Cancer survivors often arrive at our practice with more questions than a typical fertility patient, from how prior treatment may have affected their reproductive organs to whether a planned pregnancy carries additional risk. We start every consultation with a review of a patient’s cancer treatment history and, when appropriate, direct communication with their oncology team, so we understand the full picture before recommending a path forward.

From there, we build a plan around what is realistic for that patient, whether that means using previously preserved eggs, sperm, or embryos, exploring egg donation, or considering gestational surrogacy when carrying a pregnancy is not advisable. We also recognize that cancer survivors carry a different kind of emotional weight into fertility treatment, and our team takes time to address those concerns rather than rushing through a standard protocol.

Building Your Family After Cancer Treatment

Dr. Silvana Chedid and the Chedid Grieco team bring nearly 30 years of experience in reproductive medicine, FDA and New York State tissue licensing, and an approach built specifically around coordinating with oncology teams. We understand that cancer survivors weigh both medical and emotional considerations that other fertility patients may not face, and we work to give clear, honest guidance at every step rather than promising results we cannot guarantee.

If you are a cancer survivor exploring your fertility options, or you are approaching treatment and want to understand fertility preservation before you begin, our team can walk you through what is realistic for your specific situation. Consultations are held in Miami, with treatment available at our FDA- and NYDH-licensed facility in Brazil through our fertility tourism program. Reach out through our contact form to schedule a consultation.

Frequently Asked Questions About Fertility Treatment After Cancer

How long should I wait after cancer treatment before trying to conceive?

Most oncologists recommend waiting between six months and several years, depending on the type of cancer and treatment received, before attempting pregnancy. Your oncology team can confirm a safe timeline based on your specific diagnosis and treatment history.

Can I still have a biological child if I did not preserve eggs or sperm before treatment?

In many cases, yes. Some survivors retain enough reproductive function to conceive using their own eggs or sperm, while others may need egg donation, donor sperm, or gestational surrogacy depending on how treatment affected their fertility.

Is it safe to become pregnant after cancer treatment?

For many survivors, pregnancy is safe once an oncologist confirms remission and provides medical clearance. Each situation is different, so clearance from your specific cancer care team is an essential step before starting fertility treatment.

What if I need to start cancer treatment right away and cannot delay for fertility preservation?

Options such as ovarian tissue freezing for women and sperm cryopreservation for men can often be completed quickly, sometimes without meaningfully delaying cancer treatment. Ask your care team how soon these steps could be arranged.

Does fertility treatment after cancer increase the risk of recurrence?

Current research does not show that pregnancy or standard fertility treatment protocols increase recurrence risk for most cancer types, though this depends on the specific cancer and its hormone sensitivity. This is exactly why clearance from your oncologist is required before beginning treatment.

About the Author

Dr. Silvana Chedid

Reproductive Medicine Physician, Chedid Grieco

Dr. Silvana Chedid has practiced reproductive medicine for more than 25 years and introduced Intracytoplasmic Sperm Injection (ICSI) to Brazil. She leads the clinical team at Chedid Grieco, which holds consultations in Miami and provides treatment at an FDA- and NYDH-licensed facility in Sao Paulo, Brazil.

© 2025 All rights reserved - Chedid Grieco.

For First Time
Patients

Book your FREE 20 minute
appointment today!